Crescent Biopharma, Inc. (CBIO) Total assets 2016–2025
Crescent Biopharma, Inc. (CBIO) total assets at each fiscal year-end, per SEC filings.
$240.3MFY2025 · since FY2016: $42.4M → $240.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $240.3M | — |
| FY2023 | $45.3M | -12.5% |
| FY2022 | $51.8M | -45.1% |
| FY2021 | $94.3M | -33.9% |
| FY2020 | $142.8M | — |
| FY2016 | $42.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice